[Federal Register Volume 61, Number 107 (Monday, June 3, 1996)]
[Notices]
[Page 27906]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-13741]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Institute of Allergy and Infectious Diseases Special Emphasis 
Panel (SEP) meeting:

    Name of SEP: Vaccine Production Facility.
    Date: June 11, 1996.
    Time: 9:00 a.m.
    Place: Bethesda Ramada, 8400 Wisconsin Avenue, Bethesda, MD 
20814, (301) 654-1000.
    Contact Person: Dr. Madelon C. Halula, Scientific Review Adm., 
6003 Executive Boulevard, Solar Bldg., Room 4C16, Bethesda, MD 
20892, (301) 402-2636.
    Purpose/Agenda: To evaluate contract proposals.

    The meeting will be closed in accordance with the provisions set 
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

    This notice is being published less than 15 days prior to the 
meeting due to the urgent need to meet timing limitations imposed by 
the review and funding cycle.

(Catalog of Federal Domestic Assistance Programs Nos. 93.855, 
Immunology, Allergic and Immunologic Diseases Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health)

    Dated: May 28, 1996.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 96-13741 Filed 5-31-96; 8:45 am]
BILLING CODE 4140-01-M